Drug Approval | June 12, 2024
IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol
EDQM has also issued a Certificate of Suitability for Allopurino
EDQM has also issued a Certificate of Suitability for Allopurino
New software solution helps manufacturers digitalize and gain insights from data to increase efficiency
Prior to taking charge at the Union Health Ministry, Jadhav planted a sapling at his residence
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Ulcerative Colitis (UC) is a chronic, idiopathic, immune-mediated inflammatory bowel disease (IBD) affecting the large intestine
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Greg was also central to the planning, design, and construction of this facility
Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
Subscribe To Our Newsletter & Stay Updated
